Blood Thinner Recalled

Eugia US is recalling 15 500 single-dose vials of eptifibatide injection. According to the June 26, 2024, US Food and Drug Administration (FDA) Enforcement Report, the drug failed to meet impurities/degradation specifications.

The recall affects eptifibatide injection, 20 mg/10 mL (2 mg/mL), in 10-mL single-dose vials (NDC 55150-219-10), from lot 3EF22003 (Exp. 6/30/25). Manufactured in India for AuroMedics Pharma, East Windsor, New Jersey, the injection was distributed throughout the United States. 

Eugia US voluntarily initiated the recall on May 22, 2024. On June 14, 2024, the FDA designated the recall Class III, suggesting that use of the recalled drug is not likely to cause harm.

Eptifibatide injection is a prescription platelet inhibitor with indications for acute coronary syndrome and percutaneous coronary intervention.